Healthcare Professionals
Please log in for special information and services
New here?
sign up for personal account

Product Details

Esmolol® is indicated for supraventricular tachycardia and for the rapid control of the ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short-acting agent is desirable.

Amomed Pharma GmbH is the MA-Holder and AOP Orphan has the distribution rights.

Please use the emc links below to download PIL:

Esmolol 2,500mg Powder:

https://www.medicines.org.uk/emc/files/pil.3561.pdf


Esmolol 10mg/ml solution:

https://www.medicines.org.uk/emc/files/pil.3057.pdf

Drug Facts

Active ingredient

Esmolol Hydrochloride